Florida

DeSantis Announces New COVID-19 Drug Will Be Available to Floridians

Last week, the FDA granted emergency use authorization for AstraZeneca's antibody drug called Evusheld

NBC Universal, Inc.

Florida Gov. Ron DeSantis on Friday announced that a new monoclonal antibody treatment for people with serious health problems or allergies who can’t get adequate protection from vaccination will be available for Floridians soon.

DeSantis was joined by Surgeon General Dr. Joseph Ladapo in a news conference in Ocala as COVID-19 cases continue to rise in the state.

“This monoclonal is a new tool for some of our most vulnerable Floridians and we are happy to make this available throughout the state,” the governor said.

Last week, the FDA granted emergency use authorization for AstraZeneca's antibody drug called Evusheld for adults and children 12 and older whose immune systems haven't responded adequately to COVID-19 vaccines or have a history of severe allergic reactions to the shots.

Find a monoclonal antibody treatment location on the Florida Department of Health website.

As concerns grow over the omicron variant in South Florida amid an uptick in COVID-19 cases, more people are getting tested for the virus and Gov. Ron DeSantis is encouraging the use of monoclonal antibody therapy. NBC 6's Julie Leonardi has more from Tropical Park.

Patients should consult with a health care provider before receiving the treatment.

The news conference comes as daily COVID-19 cases in Florida have more than tripled in just the past few days. More than 6,800 were reported Wednesday, the most since Sept. 24, according to the CDC.

With the rise in cases and questions to be answered about the omicron variant, Miami-Dade County reinstated an emergency order requiring hospitals to report the numbers of COVID-19 cases treated each day and the availability of hospital beds.

Contact Us